-
Money /
Money News
Related Topics:
Banking & finance
Banking & finance
Global funds, from BlackRock to Temasek, back China’s largest biotech firms
Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne.
23 Jan 2026 - 8:30AM
Biomedicine: Industry Trends
Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout
21 Jan 2026 - 7:43AM
Made in China 2025
Exclusive
|
China challenges US in AI drug race, but rivals still reliant on each other
20 Jan 2026 - 11:16AM
Banking & finance
SF Holding, J&T strike US$1 billion deal as Asian e-commerce booms
The agreement will help SF Holding expand its international businesses, according to the Shenzhen-based company.
15 Jan 2026 - 4:57PM
The deal will see SF Holding acquire an 8.45 per cent stake in J&T for about HK$8.3 billion. Photo: Shutterstock Images
Made in China 2025
Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s
SciNeuro’s anti-amyloid programme is one of the firm’s key strategic research and development priorities to target the brain disease.
13 Jan 2026 - 2:02PM
videocam
Made in China 2025
China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens
Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.
13 Jan 2026 - 7:30AM
Advertisement
Advertisement
Advertisement
Banking & finance
TCM firms eye Hong Kong IPOs to fuel global expansion
Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.
8 Jan 2026 - 7:54PM
A traditional Chinese medicine pharmacy at the Hong Kong Chinese Medicine Hospital in Tseung Kwan O. Photo: Edmond So
Made in China 2025
Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025
Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.
8 Jan 2026 - 8:30AM
Made in China 2025
Meow or never: China’s pudgy pets spark race for weight-loss drugs
Fosun and Huadong biotech labs eye feline obesity drugs as owners weigh cuteness against health risks.
7 Jan 2026 - 8:30AM
Banking & finance
Citic Securities claims top spot in Asia-Pacific investment banking for 2025
Chinese rivals fill out the rest of the top five, while US bank Morgan Stanley comes in sixth.
6 Jan 2026 - 8:56PM
Banking & finance
The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.
5 Jan 2026 - 11:08AM
Healthcare firms now account for about a fifth of the more than 300 listing applications in the city. Photo: Shutterstock
IPO
China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for new drugs
US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool.
31 Dec 2025 - 2:26PM
Made in China 2025
China’s rising biotech clout on show in flurry of billion-dollar licensing deals
A burst of overseas licensing pacts is spotlighting China’s biotech sector, as Jacobio, Coherent Biopharma and Harbour BioMed land deals.
26 Dec 2025 - 10:47AM
Swire Group
Swire Pacific’s Guy Bradley to lead Hong Kong’s Cathay Pacific, Swire Coca-Cola
Bradley succeeds Patrick Healy, who will retire from the Swire Group in May next year after over three decades of service.
23 Dec 2025 - 10:19PM
Banking & finance
Global firms turn to M&A in EVs and biotech to deepen China investment: KPMG
Survey of multinational corporations finds optimism in life sciences, healthcare and manufacturing, with half forecasting revenue growth.
23 Dec 2025 - 9:30AM
Healthcare and life sciences are the top growth prospects over the next three to five years, according to multinational corporations. Photo: Xinhua
Banking & finance
Gold takes centre stage as Hong Kong builds commodities ecosystem
Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.
22 Dec 2025 - 7:15PM
United States
Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?
US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.
20 Dec 2025 - 8:57AM
Advertisement
Advertisement
Advertisement
Banking & finance
Chinese AI, chip start-ups court global investors with Hong Kong listing plans
GigaDevice and Montage are each aiming to raise as much as US$1 billion from Hong Kong listings as early as January, report says.
19 Dec 2025 - 4:30PM
The MetaX booth at the World Artificial Intelligence Conference in Shanghai, July 26, 2025. Photo: CFOTO/Future Publishing via Getty Images
Mergers & Acquisitions
Chinese brokerage CICC unveils merger details with Dongxing, Cinda
The three-way merger will create China’s fourth-largest investment bank with assets of US$128 billion.
18 Dec 2025 - 5:30PM
MetaX
MetaX stock soars 700% in Shanghai debut as traders snap up Chinese GPU maker
MetaX closes at 829.90 yuan on Wednesday, from its IPO price of 104.66 yuan, after gaining as much as 755 per cent in intraday trading.
17 Dec 2025 - 4:45PM
Made in China 2025
China’s new drug insurance: lifeline for patients or squeeze on big firms?
New insurance formulary trims costs of Alzheimer’s and cancer therapies and marks a small win for global novel drug makers.
17 Dec 2025 - 7:30AM
Made in China 2025
Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion
Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.
16 Dec 2025 - 3:47PM
A number of Chinese biotech firms have clinched licensing deals with multinational companies this year. Photo: Shutterstock
Banking & finance
Six major Hong Kong banks keep prime rates unchanged despite HKMA base rate cut
Savings rates near zero limit room for cuts as lenders protect profitability margins, analysts say.
11 Dec 2025 - 5:55PM
4
Made in China 2025
China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer
Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
10 Dec 2025 - 4:39PM
Banking & finance
Hong Kong launches HKEX Tech 100 Index in pivot towards innovation-driven growth
Unveiling of benchmark tracking Hong Kong-listed tech firms comes amid a wave of property stock delistings.
9 Dec 2025 - 5:51PM
Help preserve 120 years of quality journalism.
SUPPORT NOW
